{{Rsnum
|rsid=7834588
|Gene=NKAIN3
|Chromosome=8
|position=62971034
|Orientation=plus
|GMAF=0.4027
|Gene_s=NKAIN3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 41.5 | 44.6 | 13.8
| HCB | 28.9 | 57.8 | 13.3
| JPT | 36.9 | 52.3 | 10.8
| YRI | 17.5 | 44.4 | 38.1
| ASW | 37.5 | 41.1 | 21.4
| CHB | 28.9 | 57.8 | 13.3
| CHD | 26.2 | 59.8 | 14.0
| GIH | 16.8 | 56.4 | 26.7
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 30.3 | 45.8 | 23.9
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22437554
|Trait=None
|Title=Genome-wide association study identifies three common variants associated with serologic response to vitamin E supplementation in men.
|RiskAllele=T
|Pval=6E-7
|OR=0.0300
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}